`571-272-7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper No. 37
`
`
`Entered: November 4, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`COALITION FOR AFFORDABLE DRUGS VII, LLC,
`Petitioner,
`
`v.
`
`POZEN INC.,
`Patent Owner.
`____________
`
`Case IPR2015-01718
`Patent 8,945,621 B2
`____________
`
`
`
`Before TONI R. SCHEINER, LORA M. GREEN, and
`JACQUELINE WRIGHT BONILLA, Administrative Patent Judges.
`
`SCHEINER, Administrative Patent Judge.
`
`
`
`ORDER
`Request for Oral Argument
`37 C.F.R. § 42.70
`
`
`
`
` A
`
` trial in this proceeding was instituted on February 22, 2016. Paper 17. A
`
`Scheduling Order entered on the same date set the oral hearing for November 16,
`
`
`
`IPR2015-01718
`Patent 8,945,621 B2
`
`2016, if requested by the parties and granted by the Board. Paper 18. Patent
`
`Owner and Petitioner each requested oral hearing pursuant to 37 C.F.R. § 42.70(a).
`
`Papers 35, 36. The parties’ requests are granted according to the terms set forth
`
`below.
`
`An oral argument for IPR2015-01718 will commence at 1:00 PM Eastern
`
`Time, on November 16, 2016, on the ninth floor of Madison Building East, 600
`
`Dulany Street, Alexandria, Virginia.
`
`Each party will have 45 minutes to present arguments. Petitioner bears the
`
`ultimate burden of persuasion that the claims at issue in this review are
`
`unpatentable. Petitioner will, therefore, open the hearing by presenting its case
`
`regarding the challenged claims for which the Board instituted trial. Patent Owner
`
`then will have the opportunity to respond to Petitioner’s arguments. Petitioner may
`
`use any time it has reserved for rebuttal to respond to arguments presented by
`
`Patent Owner. Patent Owner may not reserve rebuttal time.
`
`The oral hearing will be open to the public for in-person attendance. In-
`
`person attendance will be accommodated on a first come first served basis.
`
`The Board will provide a court reporter for the hearing and the reporter’s
`
`transcript will constitute the official record of the hearing.
`
`Under 37 C.F.R. § 42.70(b), any demonstrative exhibits must be served on
`
`opposing counsel at least seven (7) business days before the hearing. The parties
`
`are directed to St. Jude Medical, Cardiology Division, Inc. v. The Board of Regents
`
`of the University of Michigan, Case IPR2013-00041 (PTAB Jan. 27, 2014) (Paper
`
`65), for guidance regarding the appropriate content of demonstrative exhibits. The
`
`Board expects that the parties will meet and confer in good faith to resolve any
`
`objections to demonstrative exhibits, but if any such objections cannot be resolved,
`
`the parties must file any objections to the demonstratives with the Board at least
`
`
`
`2
`
`
`
`IPR2015-01718
`Patent 8,945,621 B2
`
`two business days before the hearing. The objections should identify with
`
`particularity which portions of the demonstratives are subject to objection, include
`
`a copy of the objected-to portions, and include a short, one-sentence statement of
`
`the reason for each objection. No argument or further explanation is permitted.
`
`Any objection that is not timely presented will be considered waived. We note that
`
`demonstrative exhibits are only an aid to oral argument, and are not evidence of
`
`record in the proceedings.
`
`The parties also shall provide the demonstrative exhibits to the Board at least
`
`two (2) business days prior to the hearing by emailing them to Trials@uspto.gov.
`
`Despite the requirement in 37 C.F.R. § 42.70(b) for parties to file demonstratives,
`
`the parties shall not file any demonstrative exhibits in these cases without prior
`
`authorization from the Board. A hard copy of the demonstratives should be
`
`provided to the court reporter at the hearing.
`
`The parties are reminded that, during the hearing, the presenter must identify
`
`clearly each demonstrative exhibit (e.g., by referencing a specific slide or screen
`
`number) to ensure clarity and accuracy of the reporter’s transcript.
`
`The Board expects lead counsel for each party to be present at the oral
`
`hearing. Lead or backup counsel, however, may present the party’s argument. If
`
`either party anticipates that its lead counsel will not be attending the hearing, that
`
`party should initiate a joint telephone conference with the other party and the panel
`
`no later than two (2) business days prior to the hearing to discuss the matter.
`
`Any special requests for audio visual equipment should be directed to
`
`Trials@uspto.gov at least four (4) business days in advance of the hearing.
`
`
`
`
`
`3
`
`
`
`IPR2015-01718
`Patent 8,945,621 B2
`
`
`It is
`
`
`
`ORDERED that oral argument will commence at 1:00 PM ET, on November
`
`16, 2016.
`
`
`
`
`
`
`
`4
`
`
`
`IPR2015-01718
`Patent 8,945,621 B2
`
`
`
`For PETITIONER:
`
`Jerry Harris, Jr.
`Amy LaValle
`CFAD.IPRs@wickphillips.com
`
`Rodney B. Carroll
`rcarroll@dfw.conleyrose.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`IPR2015-01718
`Patent 8,945,621 B2
`
`
`
`For PATENT OWNER:
`
`Margaret Sampson, Ph.D.
`margaret.sampson@bakerbotts.com
`
`Jeffrey S. Gritton
`jeff.gritton@bakerbotts.com
`
`Dennis Bennett
`dennisbennett@globalpatentgroup.com
`
`Matthew Phillips
`matthew.phillips@renaissanceiplaw.com
`
`Thomas Blinka
`zIPR2015-01718@cooley.com
`
`Stephen M. Hash, Ph.D.
`PozenVimovoBB@BakerBotts.com
`
`Ricardo Rodriguez
`zIPR2015-01718@cooley.com
`
`Lauren Stevens
`lstevens@horizonpharma.com
`Kevin Laurence
`kevin.laurence@renaissanceiplaw.com
`
`James Monroe
`james.monroe@finnegan.com
`
`Danielle Pfifferling
`danielle.pfifferling@finnegan.com
`
`
`
`
`
`
`
`
`6
`
`